Inhibikase Therapeutics News

Inhibikase Therapeutics | 8-K: Current report

Apr 30 20:20

Inhibikase Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 30 04:41

Inhibikase Therapeutics | DEFA14A: Others

Apr 27 04:38

Inhibikase Therapeutics | ARS: Annual Report to Security Holders

Apr 27 04:27

Inhibikase Therapeutics | DEF 14A: Definitive information statements

Apr 27 04:21

Inhibikase Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Apr 26 04:31

Inhibikase Therapeutics | S-1: General form for registration of securities under the Securities Act of 1933

Apr 20 05:15

Inhibikase Therapeutics | 8-K: Current report

Apr 19 18:11

Inhibikase Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 04:14

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Werner Milton H.

Apr 4 04:51

Inhibikase Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 3 05:17

Inhibikase Therapeutics | 8-K/A: Current report (Amendment)

Apr 3 05:17

Inhibikase Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Lees-Rolfe Garth

Apr 3 05:17

Inhibikase Therapeutics | 10-K: Annual report

Mar 28 04:12

Inhibikase Therapeutics | 8-K: Current report

Feb 7 21:01

Inhibikase Therapeutics | 424B5: Prospectus

Feb 2 05:54

Inhibikase Therapeutics | 8-K: Current report

Feb 2 05:14

Inhibikase Therapeutics | 8-K: Current report

Jan 16 13:00

Inhibikase Therapeutics: Q3 2023 Earnings Report

Nov 15, 2023 05:15

Inhibikase Therapeutics | 10-K/A: Annual report (Amendment)

Oct 17, 2023 05:24